InvestSMART

CurveBeam AI Limited (ASX: CVB) - Announcements

Current share price for CVB : $0.018 0.002 (10%)+

ASX company news and announcements for CurveBeam AI Limited (CVB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CurveBeam AI Limited (CVB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CurveBeam AI Limited (CVB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CurveBeam AI Limited (CVB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Investor Presentation - Q1 FY24 Quarterly Update 31 Oct 2024 8:46AM $0.110 $0.018 fallen by 83.64%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2024 8:43AM $0.110 $0.018 fallen by 83.64%
$9 Notice of Annual General Meeting/Proxy Form 25 Oct 2024 3:09PM $0.130 $0.018 fallen by 86.15%
$9 Notification of quarterly release date and webinar 25 Oct 2024 12:21PM $0.130 $0.018 fallen by 86.15%
$9 Change in substantial holding 23 Oct 2024 4:53PM $0.140 $0.018 fallen by 87.14%
$9 Change of Director's Interest Notice - Arun Singh 17 Oct 2024 1:57PM $0.140 $0.018 fallen by 87.14%
$9 Application for quotation of securities - CVB 16 Oct 2024 9:06AM $0.135 $0.018 fallen by 86.67%
$9 Notification regarding unquoted securities - CVB 16 Oct 2024 8:55AM $0.135 $0.018 fallen by 86.67%
$9 Proposed issue of securities - CVB 15 Oct 2024 3:20PM $0.135 $0.018 fallen by 86.67%
$9 Issue Contingent Merger Consideration for CurveBeam LLC 15 Oct 2024 3:20PM $0.135 $0.018 fallen by 86.67%
$9 EGM Results of Meeting 3 Oct 2024 5:10PM $0.140 $0.018 fallen by 87.14%
$9 Appendix 4G and Corporate Governance Statement FY2024 30 Sep 2024 8:42AM $0.160 $0.018 fallen by 88.75%
$9 Annual Report to shareholders 30 Sep 2024 8:42AM $0.160 $0.018 fallen by 88.75%
$9 Investor Presentation E&P Small Cap Healthcare Conference 26 Sep 2024 10:09AM $0.175 $0.018 fallen by 89.71%
$9 Update on validation of the enhanced HiRise 25 Sep 2024 9:34AM $0.180 $0.018 fallen by 90%
$9 Date of Annual General Meeting & Director Nomination Cutoff 20 Sep 2024 3:58PM $0.165 $0.018 fallen by 89.09%
$9 Adjustment to Option Exercise Price 5 Sep 2024 3:45PM $0.185 $0.018 fallen by 90.27%
$9 Notice of Extraordinary General Meeting/Proxy Form 4 Sep 2024 4:30PM $0.185 $0.018 fallen by 90.27%
$9 FY2024 Final Audited Results Commentary 29 Aug 2024 11:15AM $0.190 $0.018 fallen by 90.53%
$9 Preliminary Final Report 29 Aug 2024 11:12AM $0.190 $0.018 fallen by 90.53%
$9 Application for quotation of securities - CVB 28 Aug 2024 10:16AM $0.180 $0.018 fallen by 90%
$9 Successful Completion of Retail Entitlement Offer 28 Aug 2024 9:09AM $0.185 $0.018 fallen by 90.27%
$9 Retail Entitlement Offer - Closing Date Reminder 21 Aug 2024 12:36PM $0.185 $0.018 fallen by 90.27%
$9 Change in substantial holding - Arun Singh 20 Aug 2024 10:18AM $0.185 $0.018 fallen by 90.27%
$9 Change in substantial holding - Ilwella Pty Ltd 19 Aug 2024 2:44PM $0.185 $0.018 fallen by 90.27%

126 - 150 of 289 results

Page 6 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.